"Join us in our mission to end type 2 diabetes."
When Dr. Kawshik Chowdhury met Dr. Wayne Lautt — cofounder of Scimar — he was…
In 1996, Dr. Wayne Lautt announced a significant discovery: there’s more to the diabetes story than insulin. He discovered a previously unidentified hormone called hepatalin (“hepata-lin”).
This hormone — known in the academic literature as hepatic insulin-sensitizing substance, or the HISS hormone — is the missing link in medicine’s understanding of type 2 diabetes, metabolic health, and nutrient partitioning. We believe hepatalin can change how the world prevents, detects, and treats type 2 diabetes.
Worldwide, cases of diabetes are steadily growing because current medical science only has part of the solution.
We’ve partnered with non-profits, industries, and Indigenous communities to build an outreach initiative that will serve as our clinical trials platform. Collaboration is key.
To wholly support your metabolic health, we’ve leveraged our scientific research to develop a morning antioxidant. It’s designed to boost metabolism, strengthen immunity, improve mood balance, and protect the liver’s production of hepatalin.
See into the scientific breakthroughs that changed the world. In this podcast, hosted by Dan Riskin of Daily Planet, we compare the modern work we’re doing at Scimar with interesting and unusual stories from science history.
"Join us in our mission to end type 2 diabetes."
When Dr. Kawshik Chowdhury met Dr. Wayne Lautt — cofounder of Scimar — he was…
We acknowledge that Winnipeg’s water is sourced from Shoal Lake 40 First Nation. Our research facilities are located on Treaty 1 territory and our head office is located on Treaty 2 territory.
Our work also extends throughout the territories of Treaties 3, 4, and 5. We acknowledge the Treaties made on these territories and we dedicate ourselves to moving forward collaboratively with
Indigenous communities in the spirit of truth and reconciliation.